Suppr超能文献

采用灵敏酶免疫分析法检测重组人甲状腺过氧化物酶自身抗体

Detection of autoantibodies to recombinant human thyroid peroxidase by sensitive enzyme immunoassay.

作者信息

Kendler D L, Martin A, Magnusson R P, Davies T F

机构信息

Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029.

出版信息

Clin Endocrinol (Oxf). 1990 Dec;33(6):751-60. doi: 10.1111/j.1365-2265.1990.tb03912.x.

Abstract

Autoantibodies to thyroid peroxidase (TPO), the thyroid 'microsomal' antigen, are widely utilized in the diagnosis of human autoimmune thyroid disease. Crude human thyroid preparations of TPO are of differing potency, contain residual thyroglobulin (Tg) and other human membrane antigens, and are available in only limited amounts. Hence, immunoassays for anti-TPO are unstandardized and of variable sensitivity and specificity. We co-transfected the Chinese hamster ovary (CHO) cell line with a full-length human TPO cDNA expression plasmid. We selected a high expressing recombinant TPO positive cell population (CHO-TPO) by Northern blot analysis, then fluorescence laser flow cytometry using both human polyclonal and murine monoclonal anti-TPO antibodies. Solubilized 100,000 g membrane preparations from both CHO-TPO and CHO cells were used as antigens in a specific ELISA with CHO antigen serving as background control. In a selected series of known anti-TPO positive (n = 46) and negative (n = 73) sera there was a high correlation between ELISAs utilizing recombinant or natural-TPO antigen (r = 0.93). There appeared to be no difference in the affinity of high titre human anti-TPO for recombinant and natural-TPO antigen with both ELISAs able to detect 0.05 U/ml of anti-TPO activity (reference preparation NIBSC 66/387). These data predict a new era in standardized thyroid autoantibody testing utilizing recombinant antigen preparations.

摘要

甲状腺过氧化物酶(TPO)即甲状腺“微粒体”抗原的自身抗体,在人类自身免疫性甲状腺疾病的诊断中被广泛应用。TPO的粗制人甲状腺制剂效价各异,含有残留的甲状腺球蛋白(Tg)和其他人类膜抗原,且数量有限。因此,抗TPO免疫测定未标准化,敏感性和特异性也各不相同。我们将全长人TPO cDNA表达质粒与中国仓鼠卵巢(CHO)细胞系共转染。通过Northern印迹分析,然后使用人多克隆和鼠单克隆抗TPO抗体进行荧光激光流式细胞术,我们选择了高表达重组TPO阳性细胞群体(CHO-TPO)。来自CHO-TPO和CHO细胞的100,000g膜制剂溶解后用作特异性ELISA中的抗原,以CHO抗原作为背景对照。在一系列选定的已知抗TPO阳性(n = 46)和阴性(n = 73)血清中,使用重组或天然TPO抗原的ELISA之间存在高度相关性(r = 0.93)。两种ELISA均能检测到0.05 U/ml的抗TPO活性(参考制剂NIBSC 66/387),高滴度人抗TPO对重组和天然TPO抗原的亲和力似乎没有差异。这些数据预示着利用重组抗原制剂进行标准化甲状腺自身抗体检测的新时代。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验